Embattled Mylan files Herceptin biosimilar in US
But senators call for investigation into EpiPen schools contracts.
X
Embattled Mylan files Herceptin biosimilar in US
https://pharmaphorum.com/news/mylan-face-antitrust-probe/
biosimilar
Education is key to US biosimilar success – Pfizer
Pfizer taking on J&J’s blockbuster Remicade.
J&J says ready to fend off Remicade competitor
Pfizer’s rival launch should be considered “at risk”, says J&J
Pfizer set for US launch of Remicade biosimilar
Pfizer gearing up for US launch late next month.
J&J’s long-lasting diabetes combo approved in US
Company looks to new drugs as US Remicade competition looms.
Sandoz’s Enbrel biosimilar approved in US
FDA approves first near-copy of inflammatory diseases drug.
Mylan and Biocon file Herceptin biosimilar in Europe
First Herceptin biosimilar filed in EU, companies say.
No US Remicade biosimilar until at least October
Pfizer must wait until 180 day period ends, court fight ongoing.
Novartis’ Enbrel biosimilar closer to market
FDA committee recommends near-copy.